EGFR c.172_173delinsGC ;(p.C58A)

Variant ID: 7-55210062-TG-GC

NM_005228.3(EGFR):c.172_173delinsGC;(p.C58A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Therapeutic Response-Based Reclassification of Multiple Tumor Subtypes Reveals Intrinsic Molecular Concordance of Therapy Across Histologically Disparate Cancers.

Frontiers In Cell And Developmental Biology
Xu, Yue Y; Zheng, Jie J; Cai, Zhaoqing Z; Li, Wang W; Köhler, Jens J; Dai, Yao Y; Cheng, Xiaojie X; Wu, Tao T; Zhang, Fan F; Wang, Haiyun H
Publication Date: 2021

Variant appearance in text: EGFR: C58A
PubMed Link: 34869372
Variant Present in the following documents:
  • Main text
View BVdb publication page



Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors.

Bmc Cancer
Kennedy, Susan A SA; Morrissey, Maria E ME; Dunne, Margaret R MR; O'Connell, Fiona F; Butler, Clare T CT; Cathcart, Mary-Clare MC; Buckley, Amy M AM; Mehigan, Brian J BJ; Larkin, John O JO; McCormick, Paul P; Kennedy, Breandán N BN; O'Sullivan, Jacintha J
Publication Date: 2020-10-02

Variant appearance in text: EGFR: C58A
PubMed Link: 33008336
Variant Present in the following documents:
  • Main text
View BVdb publication page



CHTM1 regulates cancer cell sensitivity to metabolic stress via p38-AIF1 pathway.

Journal Of Experimental & Clinical Cancer Research : Cr
Babbar, Mansi M; Huang, Ying Y; Curtiss, Christopher M CM; Sheikh, M Saeed MS
Publication Date: 2019-06-20

Variant appearance in text: EGFR: C58A
PubMed Link: 31221176
Variant Present in the following documents:
  • Main text
  • 13046_2019_Article_1253.pdf
View BVdb publication page